X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10119) 10119
Dissertation (83) 83
Book Chapter (62) 62
Conference Proceeding (16) 16
Publication (14) 14
Government Document (11) 11
Magazine Article (3) 3
Newspaper Article (2) 2
Book / eBook (1) 1
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6747) 6747
mdm2 (5290) 5290
p53 (4264) 4264
tumor suppressor protein p53 - metabolism (3688) 3688
animals (2847) 2847
oncology (2815) 2815
apoptosis (2549) 2549
proto-oncogene proteins c-mdm2 - metabolism (2487) 2487
cancer (2360) 2360
cell biology (2283) 2283
biochemistry & molecular biology (2221) 2221
tumor suppressor protein p53 - genetics (2173) 2173
female (2035) 2035
mice (1912) 1912
proto-oncogene proteins c-mdm2 (1849) 1849
proto-oncogene proteins c-mdm2 - genetics (1809) 1809
male (1679) 1679
cell line, tumor (1648) 1648
expression (1640) 1640
proteins (1387) 1387
nuclear proteins (1380) 1380
protein (1345) 1345
tumor proteins (1317) 1317
activation (1281) 1281
mdm2 protein (1247) 1247
mutation (1222) 1222
p53 protein (1212) 1212
proto-oncogene proteins - metabolism (1208) 1208
middle aged (1164) 1164
phosphorylation (1099) 1099
tumors (1067) 1067
cell cycle (1051) 1051
proto-oncogene proteins - genetics (1009) 1009
adult (965) 965
protein binding (933) 933
gene expression (924) 924
dna-damage (918) 918
aged (914) 914
gene (906) 906
research (895) 895
immunohistochemistry (865) 865
dna damage (863) 863
degradation (844) 844
ubiquitination (793) 793
signal transduction (791) 791
pathway (784) 784
genetics & heredity (783) 783
genetic aspects (746) 746
cell line (720) 720
proto-oncogene proteins c-mdm2 - antagonists & inhibitors (715) 715
in-vivo (712) 712
pathology (703) 703
apoptosis - drug effects (690) 690
nuclear proteins - metabolism (690) 690
analysis (689) 689
gene expression regulation, neoplastic (672) 672
tumor cells, cultured (654) 654
cell proliferation (624) 624
cells (623) 623
antineoplastic agents - pharmacology (619) 619
prognosis (600) 600
amplification (574) 574
wild-type p53 (569) 569
transfection (568) 568
binding (553) 553
mutations (549) 549
genes, p53 (548) 548
molecular sequence data (536) 536
multidisciplinary sciences (535) 535
inhibition (525) 525
gene amplification (523) 523
genes (515) 515
tumor suppressor genes (508) 508
biology (506) 506
tumor suppressor protein p53 - chemistry (505) 505
nuclear proteins - genetics (501) 501
ubiquitin (497) 497
health aspects (490) 490
neoplasms (482) 482
amino acid sequence (477) 477
tumor-suppressor (466) 466
tumor suppressor protein p53 - physiology (457) 457
research article (452) 452
transcription (450) 450
blotting, western (448) 448
transcriptional activation (439) 439
aged, 80 and over (438) 438
embryonic lethality (433) 433
growth (423) 423
dna (419) 419
cyclin-dependent kinase inhibitor p21 (415) 415
physiological aspects (410) 410
chemotherapy (404) 404
p53 pathway (392) 392
cells, cultured (391) 391
imidazoles - pharmacology (389) 389
binding sites (386) 386
piperazines - pharmacology (386) 386
breast cancer (379) 379
kinases (378) 378
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9883) 9883
Chinese (327) 327
French (53) 53
Japanese (44) 44
German (21) 21
Polish (12) 12
Portuguese (12) 12
Russian (12) 12
Korean (9) 9
Spanish (6) 6
Czech (5) 5
Persian (3) 3
Breton (2) 2
Hungarian (2) 2
Italian (2) 2
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2018, Volume 115, Issue 48, pp. E11311 - E11320
Journal Article
Journal Article
Journal of hematology and oncology, ISSN 1756-8722, 2017, Volume 10, Issue 1, pp. 133 - 17
The two murine double minute (MDM) family members MDM2 and MDMX are at the center of an intense clinical assessment as molecular target for the management of... 
MDM2 | Pediatric tumors | Clinical studies | Leukemia | MDMX | Pharmacological inhibitor | MULTIPLE-MYELOMA | GENE-MUTATIONS | ACUTE MYELOID-LEUKEMIA | P53 PATHWAY | TP53 MUTATIONS | B-CELL LYMPHOMA | ONCOLOGY | PHASE-I TRIAL | CHRONIC LYMPHOCYTIC-LEUKEMIA | HIGHLY POTENT | HEMATOLOGY | CHROMOSOMAL-ABERRATIONS | Proto-Oncogene Proteins c-mdm2 - genetics | Protein Interaction Maps - drug effects | para-Aminobenzoates - pharmacology | Humans | Spiro Compounds - therapeutic use | Antineoplastic Agents - therapeutic use | Hematologic Neoplasms - pathology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Imidazolines - therapeutic use | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Nuclear Proteins - genetics | Child | Proto-Oncogene Proteins c-mdm2 - antagonists & inhibitors | Proto-Oncogene Proteins c-mdm2 - metabolism | Hematologic Neoplasms - metabolism | Molecular Targeted Therapy - methods | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Tumor Suppressor Protein p53 - metabolism | Imidazolines - pharmacology | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Animals | Signal Transduction - drug effects | Nuclear Proteins - antagonists & inhibitors | para-Aminobenzoates - therapeutic use | Hematologic Neoplasms - drug therapy | Indoles - therapeutic use | Hematologic Neoplasms - genetics | Spiro Compounds - pharmacology | Pediatrics | Medical research | Clinical trials | Medicine, Experimental | Development and progression | Tumor proteins | Cancer | Cell proliferation | MDM2 protein | Animal models | Hematology | Medical innovations | p53 Protein | Genomics | Multiple myeloma | Genomes | Proteins | Side effects | Chemotherapy | Cell cycle | Lymphomas | Mutation | Chromosomes | Regulatory proteins | Tumors
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2011, Volume 17, Issue 6, pp. 536 - 559
Journal Article
Journal Article